Coenzyme Total Current Assets from 2010 to 2026

PPII Stock  USD 0.0002  0.00  0.00%   
Coenzyme A's Total Current Assets are decreasing with slightly volatile movements from year to year. Total Current Assets are predicted to flatten to about 69 K. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2010-12-31
Previous Quarter
70 K
Current Value
69 K
Quarterly Volatility
5.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Coenzyme A financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Coenzyme A's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 272.8 K or Total Revenue of 316.4 K, as well as many indicators such as . Coenzyme financial statements analysis is a perfect complement when working with Coenzyme A Valuation or Volatility modules.
  
Build AI portfolio with Coenzyme Stock
Check out the analysis of Coenzyme A Correlation against competitors.
For more detail on how to invest in Coenzyme Stock please use our How to Invest in Coenzyme A guide.
The Total Current Assets trend for Coenzyme A offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Coenzyme A is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Coenzyme A's Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Coenzyme A over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Coenzyme A's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Coenzyme A's overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Coenzyme Total Current Assets Regression Statistics

Arithmetic Mean77,763
Geometric Mean77,612
Coefficient Of Variation6.62
Mean Deviation1,990
Median77,740
Standard Deviation5,150
Sample Variance26.5M
Range25.7K
R-Value(0.63)
Mean Square Error17.2M
R-Squared0.39
Significance0.01
Slope(637.56)
Total Sum of Squares424.4M

Coenzyme Total Current Assets History

202669 K
202570 K
201177.7 K
201094.7 K

About Coenzyme A Financial Statements

Investors use fundamental indicators, such as Coenzyme A's Total Current Assets, to determine how well the company is positioned to perform in the future. Although Coenzyme A's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Total Current Assets70 K69 K

Currently Active Assets on Macroaxis

When determining whether Coenzyme A offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Coenzyme A's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Coenzyme A Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Coenzyme A Stock:
Check out the analysis of Coenzyme A Correlation against competitors.
For more detail on how to invest in Coenzyme Stock please use our How to Invest in Coenzyme A guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is there potential for Pharmaceuticals market expansion? Will Coenzyme introduce new products? Factors like these will boost the valuation of Coenzyme A. Anticipated expansion of Coenzyme directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Coenzyme A listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(35.31)
Revenue Per Share
2.652
Quarterly Revenue Growth
0.268
Coenzyme A's market price often diverges from its book value, the accounting figure shown on Coenzyme's balance sheet. Smart investors calculate Coenzyme A's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Coenzyme A's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Coenzyme A's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Coenzyme A should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Coenzyme A's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.